Safuf Mudir and Sharbat Bazuri Motadil stand therapeutic scrutiny for UTIs Reviewed by Momizat on . HERBAL CHIKITSA In patients with urinary tract infection (UTI), an inflammatory response of urothelium to bacterial invasion, Safuf mudir and Sharbat Bazuri mot HERBAL CHIKITSA In patients with urinary tract infection (UTI), an inflammatory response of urothelium to bacterial invasion, Safuf mudir and Sharbat Bazuri mot Rating: 0
You Are Here: Home » Systems of Medicine » Unani » Safuf Mudir and Sharbat Bazuri Motadil stand therapeutic scrutiny for UTIs

Safuf Mudir and Sharbat Bazuri Motadil stand therapeutic scrutiny for UTIs

Safuf Mudir and Sharbat Bazuri Motadil stand therapeutic scrutiny for UTIs

HERBAL CHIKITSA

In patients with urinary tract infection (UTI), an inflammatory response of urothelium to bacterial invasion, Safuf mudir and Sharbat Bazuri motadil play a vital role. To assess the efficacy and safety of these drugs, a study was carried out in the department of Moalijat Ajmal Khan Tibbiya College and hospital.

There are two anatomic categories of UTIs. They are: lower urinary tract infections comprising of urethritis and cystitis and the upper urinary tract infections comprising of pyelonephritis, prostatitis, and intrarenal and perinephric abscesses.

The study was conducted on 60 patients who were divided in two groups. While one group (test group) consisted of 40 members, the group other (control group had 20 members. The first group of 40 patients was prescribed 6 gram of Safuf Mudir and 20 milliliter of Sharbat Bazuri motadil twice daily for 21 days. The group of 20 was prescribed Ofloxacin 200 mg twice daily for the same duration. The data collected from the assessment carried out at weekly intervals were analysed biostatstically.

The study was an experimental randomised controlled trial performed over the period extending from 2010 to 2011 i.e. one year at the outpatients and inpatients department of Moalijat, A.K. Tibbiya College & Hospital, AMU, Aligarh.
Patients were diagnosed on the basis of subjective parameters like burning micturition, urgency, increased frequency of micturition, fever with chills, pain/tenderness in suprapubic region and loin. Objective parameters included haemogram, urine-routine and microscopic examination as well as culture, X-ray abdomen, random blood sugar, and USG abdomen.

After the treatment 84.21 per cent patients in the test group of 40 and 84.12 per cent in the control group of 20 showed improvement. The effect in the test group may be attributed to the soothing and cooling properties of tukhm-e-khayarain, tukhm- e-kharpaza, and bekh-e-kasni (Baitar, 2000; Chopra, 1958; Chugtai, 2000; Sala, 2003).

About 45 per cent patients in both the groups presented with pain in lower abdomen before the treatment. There was improvement in 72.22 per cent and 88.88 per cent patients in the test and the control groups respectively. However, tenderness present in 26 (65 per cent) patients of the test group and improvement was observed in 76.92 per cent patients.

In the control group, tenderness was observed in 12 (60′ patients and it was improved in 83.333 per cent patients after the treatment. The improvement in the test group may be due to the anti-inflammatory effect tukhm-e- khayarain, tukhm-e-kharpaza, and heel kalan (Khan, YNM).

Pus cells were present in 67.50 per cent cases in the test group, which after the treatment became normal in 66.66 per cent patients. While in the control group, the] were present in 70 per cent cases and became normal in 78.57 per cent patients (X2 = 0.03) Urine culture being a reliable objective parameter was positive in 34 (85 per cent cases in the test group, which after the termination of therapy became negative in 64.71 per cent cases. In the control group it was positive in 18 (90 per cent) patients anc became negative in 77.77 per cent cases after the termination of therapy (X2 = 0.29).

About The Author

Number of Entries : 120

Leave a Comment

Copyright © 2014herbal360. All rights reserved.

Scroll to top